ETFs Zai Lab Limited

ZLAB

US98887Q1040

Name	YTD change	Weight	AuM
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+9.43%	-	9,273 M€
VIRTUS LIFESCI BIOTECH PRODUCTS ETF - USD	+27.66%	2.07%	107 M€
TEMA ONCOLOGY ETF - USD	+18.26%	1.83%	207 M€
ALPS MEDICAL BREAKTHROUGHS ETF - USD	+8.62%	1.78%	222 M€
INVESCO GOLDEN DRAGON CHINA ETF - USD	-26.08%	1.08%	95 M€
FIDELITY DISRUPTORS ETF - USD	+8.55%	0.15%	109 M€
ISHARES BIOTECHNOLOGY ETF - USD	+25.91%	0.14%	9,953 M€
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD	+26.03%	0.05%	1,079 M€
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD	+25.70%	0.05%	78 M€
INVESCO NASDAQ BIOTECHNOLOGY ETF - USD	+25.65%	0.05%	81 M€
ACTIVEPASSIVE INTERNATIONAL EQUITY ETF - USD	+6.90%	0.02%	1,166 M€
HSBC MSCI AC ASIA PACIFIC EX JAPAN CLIMATE PARIS ALIGNED UCITS ETF - USD	+18.54%	0.01%	18 M€
STATE STREET SPDR PORTFOLIO MSCI GLOBAL STOCK MARKET ETF - USD	+10.73%	0.01%	1,756 M€
XTRACKERS EMERGING MARKETS CARBON REDUCTION AND CLIMATE IMPROVERS ETF - USD	+6.59%	0.01%	61 M€
LEUTHOLD CORE ETF - USD	+4.65%	0.01%	68 M€
FIDELITY NASDAQ COMPOSITE INDEX ETF - USD	+8.44%	0%	10,846 M€
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR	+3.54%	0%	52 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+12.04%	0%	1,674 M€
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR	-0.67%	0%	18 M€
ALPHA ARCHITECT US EQUITY 2 ETF - USD	+8.89%	0%	513 M€

Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Employees

1,784

Sector

Pharmaceuticals

More about the company